about
Assessment of cigarette smoke particle deposition within the Vitrocell® exposure module using quartz crystal microbalancesAdditive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling.Icariin ameliorates cigarette smoke induced inflammatory responses via suppression of NF-κB and modulation of GR in vivo and in vitroThe role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers.Emphysema mediated by lung overexpression of ADAM10.PKCθ synergizes with TLR-dependent TRAF6 signaling pathway to upregulate MUC5AC mucin via CARMA1.Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages.Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPDMCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium.Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.Changes in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trialGenes related to emphysema are enriched for ubiquitination pathways.Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells.Potential new drugs for therapy of chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease * 12: New treatments for COPDDenitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patientsCalorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression.Enhancement of lung tumorigenesis in a Gprc5a Knockout mouse by chronic extrinsic airway inflammation.Cigarette Smoke Decreases the Maturation of Lung Myeloid Dendritic Cells.Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway.The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.Metabolic changes of H2S in smokers and patients of COPD which might involve in inflammation, oxidative stress and steroid sensitivityDifferential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD.Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology.Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.Emerging drugs for the treatment of chronic obstructive pulmonary disease.Conserved nontypeable Haemophilus influenzae-derived TLR2-binding lipopeptides synergize with IFN-beta to increase cytokine production by resident murine and human alveolar macrophages.Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotypeCellular and biochemical bases of chronic obstructive pulmonary disease.Cigarette smoke (CS) and nicotine delay neutrophil spontaneous death via suppressing production of diphosphoinositol pentakisphosphate.Prothymosin α overexpression contributes to the development of pulmonary emphysema.Association of radiographic emphysema and airflow obstruction with lung cancer.Smad gene expression in pulmonary fibroblasts: indications for defective ECM repair in COPDMechanisms and mediators of nasal symptoms in non-allergic rhinitis.The Isosteroid Alkaloid Imperialine from Bulbs of Fritillaria cirrhosa Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat ModelInhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-meSpecific engagement of TLR4 or TLR3 does not lead to IFN-beta-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophagesPhase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years.
P2860
Q29248316-769E0DD4-3D76-4CAA-B6CC-82384D51FEF8Q30620446-A86747C0-DB88-4AB6-99C1-76E631C0D0B4Q33999187-E579515B-C7FD-4EFE-B94C-3B79B5A7D53CQ34113892-DC5DAC3D-D161-4A1B-9783-73159D4FE261Q34122816-87870DB9-FD96-4C07-B8F1-CAB572EBF45FQ34150094-0CE1D590-C054-4FB2-960B-E07BF2DEC519Q34350843-3C9AE042-DE98-41D0-9DCA-D2EF654D3E7FQ34475700-B6EEE534-B9CE-45D1-84D4-D1C86BE0DF7DQ34542927-794686C8-A282-4B21-835B-2930027FCF9BQ34598796-667AF7A2-37BA-463B-A131-64434EE50361Q34679251-5C64332A-C9A5-4115-8793-6DB7DD862EF9Q34746429-D9595A86-BA7E-4651-94DC-A1B13B70F038Q34794009-E1DB05DE-275A-4236-B087-85B6DE4E7AC0Q35047129-55D2686E-1497-46E6-8D7B-19194BB53D0EQ35164728-0555DE37-67E4-4308-9501-71C153BA312DQ35208742-D380B4B5-B9C9-41FF-942C-6203CB95B109Q35484702-14825286-15DA-4C40-8CD1-69C192BDE81AQ35574220-5BC576C6-0376-48AF-B468-3B88A066494DQ35763410-09B4A649-0610-412E-80B0-E3073CA595ECQ35983895-34EB7C9C-51C8-4F27-97B3-00F60AB9E263Q36027413-5B5458B1-F8BF-436E-9FA4-50074282112DQ36094314-8790F8A5-302D-480A-8977-1A46228D9A31Q36146643-10677C14-9D88-46CD-92BD-EACC09C9EDF9Q36146801-EF47BBDD-BF40-4F76-9E2F-03B01CCA09ADQ36195064-99638F23-AA16-43BD-99B0-8D479D1832AEQ36379352-03C9DE02-A4D8-4436-9F6A-522F6EBDE730Q36402442-65F9E1AA-3ACE-4E42-9A4B-1C25C501502BQ36458412-D11D4AFF-1162-4B14-AAEC-F8E199F6EA22Q36638466-48DBEF67-8DC6-48B8-8A49-A458C3172DD4Q36675976-43846537-2D15-4948-8E38-7C0E7DBDE785Q36726360-2C58CDE9-3856-4D3D-8B20-251622973D3DQ36835730-E9FD7F23-CECE-4BAD-BD7B-C6F4C8BB5FDAQ36906886-93B9F5D9-62B3-480F-9F71-B7EB746427DCQ36915507-BAAF0A0C-9965-4CAB-8E30-AC67B2539516Q37037103-EAAE0E3B-A699-45C9-B12A-CD8288CA660FQ37059125-DA19795B-E07F-4B1C-9F4C-719F5EBD1ABEQ37147437-638A303A-9B58-4072-899A-157999DF6EFDQ37192755-110CEAD1-528A-4232-92CB-156E49A19692Q37240141-BE6F3958-4446-4F0E-9D0C-8D0B69E410F8Q37320726-5635DAA5-3973-43E1-BE4C-4D5347EDFDDF
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New concepts in chronic obstructive pulmonary disease.
@ast
New concepts in chronic obstructive pulmonary disease.
@en
New concepts in chronic obstructive pulmonary disease.
@nl
type
label
New concepts in chronic obstructive pulmonary disease.
@ast
New concepts in chronic obstructive pulmonary disease.
@en
New concepts in chronic obstructive pulmonary disease.
@nl
prefLabel
New concepts in chronic obstructive pulmonary disease.
@ast
New concepts in chronic obstructive pulmonary disease.
@en
New concepts in chronic obstructive pulmonary disease.
@nl
P1476
New concepts in chronic obstructive pulmonary disease.
@en
P2093
Peter J Barnes
P304
P356
10.1146/ANNUREV.MED.54.101601.152209
P577
2001-12-03T00:00:00Z